-+ 0.00%
-+ 0.00%
-+ 0.00%

Allarity Therapeutics Doses First Patients in VA-Funded Phase 2 Relapsed SCLC Trial of Stenoparib Plus Temozolomide

Reuters·02/18/2026 13:15:28

Please log in to view news